Carcinogens in our environment are officially classified according to whether they are carcinogenic to humans. They are then subdivided according to the strength of the evidence. Nonetheless, some groups of people may be more sensitive than others to environmental carcinogens. One of these groups may be people who inherit defective BRCA1 or BRCA2 genes ("breast cancer genes"). Women with this inheritance have high risks for breast /ovarian cancer as a group but individual risks within this group vary greatly [Begg et al, 2008] . This variation suggests that sensitivity to environmental carcinogens and/or contributions from additional genes may modify hereditary breast cancer risks. Defective BRCA genes also increase risks for cancers in organs other than breast and ovary but individuals may differ greatly in where these other cancers occur. These individual differences may implicate an increased sensitivity to environmental carcinogens in determining the tissue specificity of BRCA associated cancers. Additional genes may be involved as well [Friedenson, 2010] .
BRCA1 and BRCA2 encode proteins required for complicated pathways to repair DNA damage. These pathways also require ATM and Fanconi proteins. Many studies show that carriers of mutations in such BRCA dependent pathways have difficulty repairing damage from DNA cross linking agents. Laboratory experiments with cells show that one of these cross linking agents is formaldehyde, a chemical that can connect strands of DNA to each other and to proteins in the vicinity of DNA.
Chromosome breaks and loss of chromosomes may occur. If cells survive and are unable to correctly repair this damage, then the strands of DNA do not reproduce faithfully and the biological instructions on DNA may be misread.
Formaldehyde is a known carcinogen that seems everywhere. Widespread exposures occur during manufacture and use of resins, particle board, plywood, leather goods, paper, pharmaceuticals, cosmetics, baby bath products, nursery furniture, and food. Annual dietary intake has been calculated as about 4,000 mg [Owen et al, 1990] .
Paints, varnishes, floor finishes, tobacco smoking, auto exhaust and organic combustion all release formaldehyde. Formaldehyde enters water from industrial wastes and may occur as a byproduct of water disinfection. Formaldehyde goods constitute 5% of US gross national product with production of nearly 5 million tons in 2003 [Zhang et al, 2010] .
In the general population, the World Health Organization's International Agency for Research on Cancer (IARC) classifies formaldehyde as a direct human mutagen and a known carcinogen proven to cause nasopharyngeal cancers and myeloid leukemia [Baan et al, 2009] . Myeloid leukemia is a malignancy of the white cells important in the first defenses against disease causing microorganisms. Epidemiological evidence found that embalming was significantly associated with an increased risk for myeloid leukemia, with significant trends for cumulative years of embalming (p trend=0.020) and for increasing peak formaldehyde exposure (p trend=0.036) [Baan et al, 2009 ].
For several years, doubts were raised about whether formaldehyde caused leukemia. Environmental formaldehyde is a water soluble gas and it was not clear how inhaling it could lead to white cell malignancies. Yet DNAprotein cross links formed by formaldehyde routinely served as a measurement for its concentration within cells.
Then chromosome breaks and leukemiaspecific chromosome changes [Zhang et al, 2010; Baan et al, 2009] were found in precursors of myeloid white cells. Nasal epithelium in rats had been known to contain stem cells capable of forming myeloid white cell producing tissue [National toxicology program, 2010] . This then provided a plausible way carcinogenic damage to nasal stem cells from inhaled formaldehyde could develop into myeloid leukemia. This possibility is further supported by the elevated incidence rate of leukemia and other hematological malignancies in individuals with nasopharyngeal cancer. Identification of genetic susceptibility loci for nasopharyngeal cancer found these loci were also all involved in leukemogenesis.
This suggests a partially shared pathogenic mechanism between hematologic malig nancy and nasopharyngeal cancer [Bei et al, 2010] . Repairing such complex DNA damage requires homologous recombination pathways [Nakano et al, 2007] and repair pathway coordination mediated by BRCA1, BRCA2 (Fanconi protein D1), and 12 other Fanconi proteins. Inherited mutations interfere with these repairs and are associated with leukemias, especially myeloid leukemias. This association is quite clear for some homozygotes. Six children with biallelic BRCA2 mutations all developed leukemia at median age 2.2 years, with 4 of 6 developing acute myeloid leukemia (AML) [Wagner et al, 2004] . A review of all biallelic BRCA2 mutation patients found a 79% cumulative probability of leukemia (primarily AML) by age 10 years [Alter et al, 2007] . In Fanconi anemia homozygotes, summary relative risks for AML were 703.3 [363.7-1354.5] [Friedenson, 2007] .
With more limited evidence, the IARC also implicated formaldehyde in the very rare cancer, sinonasal cancer [Baan et al, 2009; National Toxicology Program, 2010] .
The annual incidence of nasal tumors in the United States is estimated to be less than 1 in 100,000 people per year with females having half the incidence of males. Nasal sinus cancer has been reported in heterozygous BRCA1 mutation carriers [Thompson et al, 2002] . Two nose cancers were found in heterozygous BRCA2 carriers [Breast cancer linkage consortium, 1999] . Both the BRCA1 and BRCA2 studies contained far less than 100,000 people, primarily women; so risks for cancers of the nose were elevated. However, cancers involving the nose were grouped among "other cancers", preventing relative risk calculations.
The Fanconi core subcomplex (containing Fanconi proteinsA, B, C, E, F, G, L, and FAAP100) promotes translesion synthesis by error tolerant polymerases.
Translesion synthesis probably keeps stalled replication forks from breaking, thereby maintaining chromosome continuity [Thompson and Hinz, 2009] . Ridpath et al [2007] assessed the DNA damage response to plasma formaldehyde using chicken DT40 cells with targeted mutations in various DNA repair genes. DT40 mutants deficient in the BRCA/Fanconi pathway, homologous recombination, or translesion DNA synthesis were hypersensitive to formaldehyde. The most sensitive mutants were deficient in BRCA2 or Fanconi proteinD2. Human cells deficient in core complex Fanconi proteins C and G were also hypersensitive to plasma formaldehyde [Ridpath et al, 2007] .
In addition to requiring BRCA and Fanconi proteins, complex DNA damage and replication fork stalling also activate ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3related (ATR) kinases, and downstream checkpoint kinases CHK2 and CHK1. Hereditary cancerprone conditions are known that relate to inherited defects in some of these genes. In 1976 it was widely recognized that ataxia telangiectasia patients (homozygous ATM mutation) are very likely to develop cancers that have some association to formaldehyde exposure. Hematologic malignancies that caused premature deaths in blood relatives from 27 families of ataxiatelangiectasia patients included Hodgkins disease, monocytic leukemia, acute myeloid leukemia, and lymphatic leukemia. Five deaths from leukemias and lymphomas occurred below age 45 in comparison to 1 expected death [Swift et al, 1976] . The overall excess cancer risk in heterozygous ATM mutation carriers younger than 50 years of age appeared to be due to several different cancer types including nasopharyngeal cancer in the 6yearold brother of an ataxiatelangiectasia patient; this was the only juvenile cancer in a relative [Thompson et al, 2005] . Weaker evidence suggests increased risk for rare nasopharyngeal or sinonasal cancers in heterozygous BRCA1/2 mutation carriers and in ATM mutation carriers.
It should be stressed that the above evidence is not incontrovertible proof that formaldehyde causes excess hematologic cancer risks in mutation carriers that goes beyond formaldehyde cancer risks in normal individuals. There is virtually no information on its effect on breast and ovarian cancer risk in mutation carriers.
However, formaldehyde is a pervasive environmental carcinogen that is theoretically more likely to cause malignancy in carriers of mutations that disable protective repair pathways. Because of this uncertainty it is prudent for mutation carriers to immediately avoid formaldehyde, especially high level exposure. The EPA recommends four basic "Steps to Reduce Exposure" for everyone.
Use "exteriorgrade" pressed wood products (loweremitting because they contain phenol resins, not urea resins).
Use air conditioning and dehumidifiers to maintain moderate temperature and reduce humidity levels.
Increase ventilation, particularly after bringing new sources of formaldehyde into the home.
Ask about the formaldehyde content of pressed wood products, including building materials, cabinetry, and furniture before you purchase them.
